20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Rezolute, Inc. - Common Stock (NV) (RZLT) operates in the NASDAQ industry and is headquartered in Redwood City, United States with about 58 employees. Its market capitalization is roughly $382 million.
Rezolute, Inc., a late-stage rare disease company, focuses developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism (HI) in the United States.
Interactive charts & full statements →
| Income statement | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | — | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | — | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | ($13M) | ($8M) | ($6M) | ($2M) | ($5M) | $0M |
| Gross Margin % | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income (EBIT) | ($83M) | ($83M) | ($80M) | ($70M) | ($56M) | ($42M) | ($23M) | ($21M) | ($26M) | ($29M) | ($20M) | ($15M) | ($11M) | ($5M) | ($6M) | $0M |
| Operating Margin % | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | ($78M) | ($78M) | ($74M) | ($68M) | ($52M) | ($41M) | ($21M) | ($20M) | ($30M) | ($30M) | ($20M) | ($15M) | ($11M) | ($10M) | ($7M) | $0M |
| Net Margin % | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | ($79M) | ($83M) | ($74M) | ($68M) | ($52M) | ($39M) | ($21M) | ($20M) | ($25M) | ($25M) | ($19M) | ($14M) | ($11M) | ($5M) | ($6M) | $0M |
| Earnings Per Share (EPS) | $-0.75 | $-0.75 | $-0.98 | $-1.33 | $-1.01 | $-2.11 | $-2.72 | $-3.54 | $-17.11 | $-26.83 | $-24.55 | $-30.14 | $-27.12 | $-51.84 | $-54.21 | $-0.64 |
| Shares Outstanding (M) | 104M | 104M | 76M | 51M | 51M | 19M | 8M | 6M | 2M | 1M | 1M | 0M | 0M | 0M | 0M | 0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Margin % | — | — | — | — | -17.4% | — | — | — |
| Operating Income (EBIT) | ($22M) | ($17M) | ($24M) | ($20M) | ($26M) | ($20M) | ($17M) | ($17M) |
| Operating Margin % | — | — | — | — | -56195.7% | — | — | — |
| Net Income | ($20M) | ($16M) | ($23M) | ($18M) | ($24M) | ($19M) | ($16M) | ($15M) |
| Net Margin % | — | — | — | — | -53021.7% | — | — | — |
| EBITDA | ($22M) | ($16M) | ($23M) | ($18M) | ($24M) | ($19M) | ($16M) | ($15M) |
| Earnings Per Share (EPS) | $-0.20 | $-0.16 | $-0.22 | $-0.18 | $-0.26 | $-0.27 | $-0.22 | $-0.22 |
| Shares Outstanding (M) | 104M | 104M | 104M | 103M | 94M | 70M | 70M | 70M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($65M) | ($65M) | ($69M) | ($57M) | ($44M) | ($40M) | ($20M) | ($24M) | ($15M) | ($14M) | ($13M) | ($10M) | ($7M) | ($3M) | ($2M) | $0M |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $2M | $3M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($65M) | ($65M) | ($69M) | ($57M) | ($45M) | ($40M) | ($21M) | ($24M) | ($15M) | ($14M) | ($14M) | ($13M) | ($10M) | ($3M) | ($2M) | $0M |
| FCF Margin % | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($13M) | ($14M) | ($20M) | ($17M) | ($22M) | ($17M) | ($14M) | ($16M) |
| Free Cash Flow (FCF) | ($13M) | ($14M) | ($20M) | ($17M) | ($22M) | ($17M) | ($14M) | ($16M) |
| FCF Margin % | — | — | — | — | -47815.2% | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $113M | $113M | $175M | $133M | $124M | $152M | $43M | $11M | $12M | $3M | $11M | $11M | $11M | $7M | $1M | $1M |
| Cash & Cash Equivalents | $11M | $11M | $94M | $70M | $16M | $150M | $41M | $10M | $12M | $2M | $4M | $4M | $5M | $6M | $0M | $0M |
| Total Liabilities | $12M | $12M | $13M | $12M | $8M | $3M | $17M | $4M | $10M | $6M | $2M | $2M | $2M | $1M | $5M | $2M |
| Total Debt (Short + Long-Term) | $1M | $1M | $1M | $1M | $1M | $1M | $14M | $0M | $0M | $3M | $0M | $0M | $0M | $0M | $4M | $2M |
| Total Shareholders' Equity | $101M | $101M | $162M | $121M | $116M | $149M | $26M | $7M | $2M | ($4M) | $9M | $9M | $9M | $6M | ($4M) | ($1M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RZLT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms